The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The use of exosome and immune profiling to analyze a phase 2 study on the addition of patritumab or placebo to cetuximab and a platinum agent for recurrent / metastatic head and neck cancer (R/M HNSCC) patients.
 
Tony Ng
Research Funding - AstraZeneca; Daiichi Sankyo
 
Fabian Flores-Borja
No Relationships to Disclose
 
Giovanna Alfano
No Relationships to Disclose
 
Paul Barber
No Relationships to Disclose
 
Gregory Weitsman
No Relationships to Disclose
 
Felix Wong
No Relationships to Disclose
 
Jose Vicencio
No Relationships to Disclose
 
Myria Galazi
No Relationships to Disclose
 
Jana Doyle
Employment - Daiichi Sankyo
Stock and Other Ownership Interests - Daiichi Sankyo; Pfizer
Research Funding - Daiichi Sankyo; Novartis
Other Relationship - Daiichi Sankyo
 
Jonathan Greenberg
Employment - Daiichi Sankyo
Leadership - Daiichi Sankyo
Stock and Other Ownership Interests - Daiichi Sankyo
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Martin David Forster
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Clovis Oncology; Lilly; Merck; Novartis; Pfizer
Travel, Accommodations, Expenses - Boehringer Ingelheim; Lilly; Merck; MSD; Pfizer; Roche
 
Anthonius Coolen
No Relationships to Disclose